Rivaroxaban Versus Standard of Care for Patients With Excessive Atrial Ectopy or Short Atrial Runs and High Embolism Risk
Clinical trial NCT05487950 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05487950
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-05
- Primary completion
- 2027-04-05
- Enrollment
- 550
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.